Genomic Alterations Distinct for Black Men With Prostate Cancer
Frequencies of genomic alterations in current therapeutic targets similar for AFR, EUR men.
Frequencies of genomic alterations in current therapeutic targets similar for AFR, EUR men.
For men in VA health system, blacks do not present with more advanced disease or have higher mortality.
In a study that evaluated outcomes for younger, working age women with breast cancer, researchers identified differences in cancer-related financial adverse events in black women vs white women.
An analysis of SEER data sought to examine the appropriateness of age- and race-specific breast cancer screening recommendations for white vs nonwhite women in the United States.
Retrospective study examines the association between risk of cardiotoxicity and race in women with breast cancer receiving chemotherapy and at least 1 year of HER2-targeted therapy.
Community-based, interventionist-guided weight loss program was efficacious for early-stage survivors.
Family history does not predict aggressiveness of prostate cancer or suitability for active surveillance as a treatment option.
A report on incidence of thyroid cancer shows incidence of the disease is increasing among certain populations: younger persons, Hispanic, and African American.
Although median survival is longer for Hispanic and black patients compared with white patients, health-related QoL is poor for minority patients.
NCI awarded a $9 million grant to Barbara A. Karmanos Cancer Institute and Wayne State University to explore factors contributing to racial disparities in cancer.